Dendreon Quick Ratio (DNDN) starting from the third quarter 2014 to third quarter 2013, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Dendreon Corp  (DNDN)

Dendreon's Quick Ratio

DNDN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2014, Quick Ratio deteriorated to 1.68 below Dendreon's average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 54 other companies have achieved higher Quick Ratio than Dendreon in third quarter 2014. While Quick Ratio total ranking has improved so far during the Q3 2014 to 1205, from total ranking in the second quarter 2014 at 1452.

Explain Quick Ratio?
How much Cash & cash equivalents DNDN´s has?
What are DNDN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNDN Quick Ratio (Sep 30 2014)
Q3		 (Jun 30 2014)
Q2		 (Mar 31 2014)
Q1		 (Dec 31 2013)
Q4		 (Sep 30 2013)
Q3
Y / Y Current Liabilities Change -42.64 % -33.57 % 17.24 % -0.17 % 10.42 %
Y / Y Cash & cash equivalent Change -35.87 % -38.63 % -43.62 % -49.23 % -57.3 %
Quick Ratio MRQ 1.68 1.73 1.53 1.73 1.5
DNDN's Total Ranking # 1205 # 1452 # 1309 # 1475 # 1334
Seq. Current Liabilities Change -13.77 % -27.5 % -2.08 % -6.31 % -0.13 %
Seq. Cash & cash equivalent Change -16.05 % -17.95 % -13.62 % 7.79 % -19.66 %



Quick Ratio third quarter 2014 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 55
Healthcare Sector # 382
Overall Market # 1205


Quick Ratio Statistics
High Average Low
5.76 2.82 1.5
(Mar 31 2012)   (Sep 30 2013)




Financial Statements
Dendreon's Current Liabilities $ 64 Millions Visit DNDN's Balance sheet
Dendreon's Cash & cash equivalent $ 107 Millions Visit DNDN's Balance sheet
Source of DNDN's Sales Visit DNDN's Sales by Geography


Cumulative Dendreon's Quick Ratio

DNDN's Quick Ratio for the trailling 12 Months

DNDN Quick Ratio

 (Sep 30 2014)
12 Months		 (Jun 30 2014)
12 Months		 (Mar 31 2014)
12 Months		 (Dec 31 2013)
12 Months		 (Sep 30 2013)
12 Months
Y / Y Current Liabilities TTM Growth -16.91 % -2.99 % 11.46 % 7.66 % 15.63 %
Y / Y Cash & cash equivalent TTM Growth -43.28 % -48.75 % -51.16 % -50.48 % -51.24 %
Quick Ratio TTM 1.66 1.61 1.66 2.01 2.43
Total Ranking TTM # 3343 # 3555 # 666 # 3319 # 3376
Seq. Current Liabilities TTM Growth -12.12 % -8.72 % 3.62 % -0.04 % 2.6 %
Seq. Cash & cash equivalent TTM Growth -9.51 % -11.3 % -14.48 % -17.36 % -18.23 %

Quick ratio ranking by company, industry and sector >> Back to DNDN Financial Strength Comparisons >> Go to Compare DNDN Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Dendreon's average Cash & cash equivalent, this led to increase in in Dendreon's Quick Ratio to 1.66, Quick Ratio remained below DNDN average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 41 other companies have achieved higher Quick Ratio than Dendreon. While Quick Ratio overall ranking has improved so far to 3343, from total ranking during the twelve months ending second quarter 2014 at 3555.

Explain Quick Ratio?
How much Cash & cash equivalents DNDN´s has?
What are DNDN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 42
Healthcare Sector # 380
Within the Market # 3343


trailing twelve months Quick Ratio Statistics
High Average Low
4.37 2.65 1.61
(Dec 31 2012)   (Jun 30 2014)




Companies with similar Quick Ratio in the quarter ending Sep 30 2014, within Biotechnology & Pharmaceuticals Industry Quick RatioSep 30 2014 MRQ Cash & cash equivalentSep 30 2014 MRQ Current Liabilities
Brainstorm Cell Therapeutics inc   4.41 $ 10.569  Millions$ 2.395  Millions
Nanostring Technologies Inc   4.38 $ 67.500  Millions$ 15.404  Millions
Pharmacyte Biotech Inc   4.17 $ 1.155  Millions$ 0.277  Millions
Halozyme Therapeutics Inc   3.89 $ 134.464  Millions$ 34.593  Millions
Armata Pharmaceuticals Inc   3.86 $ 9.786  Millions$ 2.535  Millions
Cel sci Corporation  3.42 $ 10.785  Millions$ 3.153  Millions
Agenus Inc  3.39 $ 52.908  Millions$ 15.610  Millions
Amgen Inc   3.28 $ 28,075.000  Millions$ 8,551.000  Millions
Bio techne Corp  3.22 $ 130.812  Millions$ 40.618  Millions
Vaxart Inc   3.14 $ 58.800  Millions$ 18.700  Millions
Vericel Corporation  3.01 $ 37.578  Millions$ 12.482  Millions
Seagen Inc   2.85 $ 339.561  Millions$ 119.129  Millions
Biocryst Pharmaceuticals Inc   2.55 $ 127.284  Millions$ 49.823  Millions
Protalix Biotherapeutics inc   2.47 $ 60.317  Millions$ 24.384  Millions
Eloxx Pharmaceuticals Inc   2.27 $ 3.837  Millions$ 1.687  Millions
Coherus Oncology inc   2.20 $ 100.925  Millions$ 45.781  Millions
Cellular Biomedicine Group Inc   2.01 $ 9.816  Millions$ 4.895  Millions
China Biologic Products Holdings Inc   1.77 $ 139.984  Millions$ 79.090  Millions
Dendreon Corp  1.68 $ 106.861  Millions$ 63.524  Millions
Moderna Inc   1.40 $ 3.203  Millions$ 2.280  Millions
Qiagen N v   1.34 $ 576.703  Millions$ 431.626  Millions
Lineage Cell Therapeutics Inc   1.27 $ 7.416  Millions$ 5.831  Millions
Polarityte Inc   1.22 $ 7.196  Millions$ 5.905  Millions
Exelixis Inc   1.17 $ 204.212  Millions$ 173.912  Millions
Gilead Sciences Inc   1.04 $ 6,316.326  Millions$ 6,054.952  Millions
Bohai Pharmaceuticals Group, Inc.  1.02 $ 49.514  Millions$ 48.767  Millions
Titan Pharmaceuticals Inc   1.00 $ 7.450  Millions$ 7.461  Millions
Biogen Inc   0.96 $ 1,861.346  Millions$ 1,940.647  Millions
Premier Biomedical Inc  0.88 $ 0.047  Millions$ 0.053  Millions
Xtant Medical Holdings Inc   0.74 $ 6.953  Millions$ 9.376  Millions

Date modified: 2026-09-08T15:07:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.